Page last updated: 2024-10-30

leflunomide and Corridor Disease

leflunomide has been researched along with Corridor Disease in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamyingkird, K1
Cao, S1
Tuvshintulga, B1
Salama, A1
Mousa, AA1
Efstratiou, A1
Nishikawa, Y1
Yokoyama, N1
Igarashi, I1
Xuan, X1

Other Studies

1 other study available for leflunomide and Corridor Disease

ArticleYear
Effects of dihydroorotate dehydrogenase (DHODH) inhibitors on the growth of Theileria equi and Babesia caballi in vitro.
    Experimental parasitology, 2017, Volume: 176

    Topics: Amino Acid Sequence; Animals; Antiprotozoal Agents; Atovaquone; Babesia; Babesiosis; Biphenyl Compou

2017